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Purpose: Because homologous vein is rarely used in vascular reconstructions, weevaluated 
the homologous vein as a patch for the reconstruction f the carotid bifurcation after 
endarterectomy. 
Methods: Excess vein harvested uring open heart operations was either refrigerated in
saline solution or cryopreserved in a solution of 10% dimethyl sulfoxide. Donors were 
tested for transmissible infections, and the veins were cultured for common pathogens. 
Data were analyzed from 837 consecutive patients (1006 cases) who underwent carotid 
endarterectomy with homologous vein patch angioplasty between 1981 and 1993. 
Results: The perioperative mortality rate was 0.8% (eight patients). Two deaths (0.2%) 
were attributed to ipsilateral strokes. Ischemic strokes occurred in 12 patients (1.2%; 10 
ipsilateral), and ipsilateral transient ischemic attacks occurred in three patients (0.3%). 
Follow-up data were obtained for 482 patients (56%; mean follow-up time, 61 months; 
range, I to 132 months). Ipsilateral recurrent symptoms occurred in eight patients (1.7%; 
seven strokes, one transient ischemic attack). Of the 63 late deaths (13%), the majority (25 
patients; 40%) were caused by complications ofcoronary artery disease. The 10-year overall 
survival rate was 76% + 3.2%, and the 10-year ate of freedom from late ipsilateral 
morbidity was 96% + 1.4%. The 10-year rate of freedom from late stenosis (a reduction in 
diameter of >20%) in the 220 arteries (22%) that were studied by duplex scan was 
84% + 2.3%. 
Conclusions: The postoperative mortality and neurologic morbidity rates of carotid 
endarterectomy with homologous vein patch angioplasty are similar to those in the best 
series with all types of closure. The existing long-term follow-up data indicate that the 
homologous vein is a durable patch that behaves like other patches used in the same 
location. (J Vasc Surg 1996;24:109-19.) 
Carotid endarterectomy is a well-established 
treatment for preventing stroke in selected patients. 1,2 
Although controversy exists regarding the use of 
primary closure versus patch angioplasty 3-s for recon- 
struction of  the bifurcation after carotid endarterec- 
tomy, evidence is increasing in the literature in sup- 
port of patch angioplasty. 6 13 
Various materials have been used as a patch in this 
procedure, including the saphenous vein and syn- 
thetic patches. Autologous saphenous vein patches 
cause less bleeding, can be handled more easily, and 
may be less thrombogenic than the synthetic patches. 
The use ofautologous saphcnous vein, however, does 
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require an extra incision and the presence of a suitable 
segment of vein. Its use also may be associated with 
wound complications, especially in patients with pe- 
ripheral vascular disease, and may render the remain- 
ing vein unsuitable for later vascular or cardiac recon- 
struction. To overcome these actual and potential 
problems, since 1968 we have routinely used homolo- 
gous vein to reconstruct the bifurcation after carotid 
cndarterectomy. We have, however, sometimes used 
autologous vein in patients who underwent simulta- 
neous coronary artery bypass and carotid endarterec- 
tomy, provided that they had enough vein of good 
quality for both reconstructions. 
We report here our experience with 1006 con- 
secutivc cases of carotid endarterectomy in which 
patch angioplasty was performed with homologous 
vein. 
MATERIALS AND METHODS 
Study design. We reviewed the records of 837 
consecutive patients who underwent 1006 carotid 
109 
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Table I. Vein culture serology 
HbsAg, HCV, HBC-Ab 
HTLV- 1, HIV-1,2 
SGOT (ALT) 
RPR* 
*rapid plasma reagent 
endarterectomies with homologous vein patch angio- 
plasty between January 1981 and December 1993. 
The records included the patients' preoperative pro- 
files, common operative details, and long-term post- 
operative follow-up. In addition, between July 1993 
and December 1993, a detailed three-page question- 
naire was mailed to patients and their families in an 
attempt o obtain the latest follow-up data. The 
questionnaire asked about he development ofsymp- 
toms in the territory of the endarterectomized and 
contralateral carotid arteries. If a response indicated 
that a problem related to the previous carotid endar- 
terectomy had developed, a personal telephone inter- 
view was arranged. If a patient did not respond, an 
attempt was made to contact the closest relatives. We 
received responses to the questionnaire from 482 
patients (56%). Because patients were referred to the 
vascular service from a large geographic area and the 
time frame of the study was long, the number of 
responses was somewhat low. 
Vein harvesting and processing. Excess vein of 
good quality harvested during coronary artery bypass 
procedures can be stored and used later. For short- 
term storage (up to 3 days) veins were refrigerated in
an antibiotic (penicillin, 25,000 units) containing 
saline solution at 4 ° C. For long-term storage (up to 
3 years) the veins were cryopreserved in a 10% di- 
methyl sulfoxide (DMSO)-based solution at-120 °C. 
The solution was prepared by mixing 450 cm a of 
culture media with 50 cm 3 of DMSO, 500 mg of 
vancomycin, and 25,000 units of penicillin. 
All vein patches were harvested exclusively from 
the thigh. Small (diameter <3 mm on distention), 
thin-walled veins were automatically discarded. 
Donors were thoroughly scrutinized for transmis- 
sible infections, and the harvested veins were cultured 
for common pathogens before being stored. If results 
were within normal limits for this series of tests (Table 
I), the veins were considered acceptable for use. 
During the last 5 years of the study the donors' ABO 
blood types were also obtained for routine match with 
the future recipients. 
Patient data. Of 837 patients who underwent 
carotid endarterectomy, 503 (60%) were men and 
334 (40%) were women. The mean age was 67; the 
range was 34 to 90 years. Three-hundred ninety-five 
patients (47%) had a history of hypertension; diabetes 
mellitus controlled with diet or requiring insulin or 
oral hypoglycemic agents was present in 108 patients 
(13%); 301 patients (36%) had a history of coronary 
artery disease, and 493 patients (59%) were smokers 
(past or present) at the time of surgery. 
Operative information. Unilateral carotid en- 
darterectomies were performed in 673 patients 
(80%), whereas 164 (20%) required bilateral proce- 
dures. Five patients in the bilateral group required a
third (redone) operation during the study period. 
One hundred seven carotid endarterectomies (10.7%) 
were performed simultaneously with other proce- 
dures, most frequently open heart operations (67 
patients, 6.6%); seven patients (0.6%) had simulta- 
neous carotid-subclavian bypass to alleviate stenosis at 
the origin of the common carotid artery, 11 patients 
(1.1%) had concomitant abdominal ortic aneurysmal 
resection, and six patients (0.6%) underwent other 
peripheral vascular procedures. Sixteen patients 
(1.6%) underwent general surgical procedures. 
Thirty-three patients (33%) underwent redo opera- 
tions in this series. 
One hundred thirty-five patients (13.5%) had 
previously had complete strokes followed by good 
functional recovery, 452 (44.5%) had had transient 
ischemic attacks (TIAs) or episodes of amaurosis 
fugax, and 84 (8.4%) had nonhemispheric symp- 
toms. Three hundred thirty-five patients (33.3%) 
had asymptomatic high-grade (>75%) carotid 
stenosis. 
All procedures were performed under general 
endotracheal nesthesia and systemic heparinization 
that was reversed with protamine sulfate at the con- 
clusion of each operation. The mean carotid clamp 
time was 26 minutes, with a range of 16 to 40 
minutes. 
Shunts were used in selected patients. Since 1988 
intraoperative lectroencephalographic monitoring 
has been used routinely, and changes in the elec- 
troencephalogram pattern after cross-clamping that 
do not respond to an increase in the mean arterial 
pressure are considered indications for shunting. On 
the basis of this criterion, 40 of 357 patients (11%) 
required ashunt. Before 1988, poor internal carotid 
artery backbleeding and occasionally stamp pressure 
measurements were used to identify patients at high 
risk for intraoperative stroke. Shunts were used in 13 
of 649 patients (2%) during that period. 
Angiographic data. Preoperative angiography 
was performed in each of the 837 patients. Severe 
stenosis (>75% diameter reduction) of the ipsilateral 
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carotid artery was demonstrated in 682 cases (68%). 
The contralateral internal carotid artery was severely 
stenosed (___75% diameter reduction) in 115 patients 
( 11.5 %) and was occluded in 75 patients ( 7.5 % ). The 
percentage of diameter reduction was measured rela- 
tive to the outflow vessel, according to the guidelines 
set by the International Society for Cardiovascular 
Surgery (North American Chapter) and Society for 
Vascular Surgery Subcommittee on Reporting Stan- 
dards for Cerebrovascular Disease. 14 
Duplex data. Objective reassessment has been 
obtained for 220 arteries (22%; mean duplex fol- 
low-up time, 42 months; range, 1 to 120 months). 
Duplex ultrasonography and angiography were per- 
formed when needed to evaluate the arteries. All 
duplex scans were obtained in our accredited vascular 
laboratory with an Ultramark duplex scanning system 
(Advanced Technology Laboratory, Bothcll, Wash.). 
Significant carotid artery stenosis (50% to 75% diam- 
eter reduction) was diagnosed when peak systolic 
frequencies >4 kHz were found. End diastolic fre- 
quencies >4.5 l~Hz with marked spectral broadening 
were diagnostic of severe stenosis (diameter reduction 
>75%). Total occlusion was indicated by the lack of a 
flow signal in an adequately visualized artery with a 
low or reversed iastolic omponent in the common 
carotid artery. 
Histologic data. Histologic analysis of six ho- 
mologous vein patches harvested uring repeat op- 
erations was performed. We demonstrated that a 
discrete cellular adventitial layer was present in all of 
the patches. The media had variable muscle and elastic 
fiber content. Areas of fibrointimal proliferation were 
evident, and the inner surface of the veins was covered 
by a thin layer ofendothelium. No inflammatory cells 
were seen in the wall of the vein patches (Figs. 1 and 
2). These histologic haracteristics demonstrate hat 
the veins were well incorporated into the recipient 
tissues. 
Statistical analysis. Data abstracted from charts 
were entered in a custom-designed database created 
in 4th Dimension Relational database for Macintosh, 
version 2.2 (ACIUS, Inc., Cupertino, Calif.) and 
subsequently transferred to a DEC VAX 11/750 
running VAX/NMS (Digital Equipment Corp., May- 
nard, Mass.). Univariate analysis testing included 
Fisher's Exact Test and Pearson's g2 test for categoric 
data and Student's t test for continuous variables. 
Kaplan-Meier curves were used to estimate the time- 
related probabilities of survival (rate of freedom from 
late death), rate of freedom from late stroke, and rate 
of freedom from recurrent stenosis. The generalized 
Wilcoxon %2 was the test of choice for Kaplan-Meicr 
analysis. Multivariate analysis was performed with 
Cox's logistic regression method to identify the 
independent predictors of perioperative and late 
death and neurologic morbidity, as well as the predic- 
tors of late restenosis. The BMDP statistical software 
1990 package (BMDP Statistical Software, Inc., Los 
Angeles) was used for all statistical computations. 
RESULTS 
Early results. The hospital mortality rate was 
0.8% (eight deaths) in this series. Of these eight 
patients, only two (0.2%) had fatal complications that 
were related to strokes in the territory of the endar- 
terectomized carotid artery. Ipsilateral electroen- 
cephalogram changes developed in one patient after 
carotid cross-clamping, and a shunt was placed. De- 
spite the shunt he electroencephalogram changes did 
not reverse, and the patient had a massive ipsilateral 
ischemic stroke immediately after surgery. He subse- 
quently died of complications from the stroke. The 
second patient had an embolic stroke in the territory 
of the endarterectomized carotid artery 8 days after 
surgery. Selective carotid arteriography revealed a 
patent reconstruction. Subsequently the patient had 
an embolic occlusion of the infrarenal aorta, which 
required emergency operative intervention. After sur- 
gery the patient had a cardiac arrest and died. 
Four other patients underwent major vascular 
(n = 1) and open heart (n = 3) operations at the same 
time as endarterectomy and died of complications 
from the other procedures. Two deaths were attrib- 
uted to aspiration pneumonia with subsequent devel- 
opment of severe adult respiratory distress yndrome. 
I'erioperative and postoperative complica- 
tions. Perioperative strokes with significant func- 
tional impairment occurred in 12 cases (1.2%). Symp- 
tomatic cerebrovascular disease was present in 10 
patients (1%) before surgery: five patients had strokes, 
three had TIAs, and two had nonhemispheric symp- 
toms. Of these strokes, 10 were ipsilateral to the 
carotid surgery and two involved the contralateral 
hemisphere in the presence of normal contralateral 
carotid arteries. Seven of the 12 strokes were discov- 
ered when the patient awakened from general anes- 
thesia. The other five strokes occurred 2to 5 days after 
surgery. In three of these five cases, objective studies, 
including carotid arteriography, confirmed a source 
other than the endarterectomized carotid artery. In 
two patients, the symptoms of a recent cerebrovascu- 
lar accident (CVA) grew worse after surgery. These 
patients did not undergo arteriography, but no other 
source responsible for the postoperative d terioration 
of their condition was identified. Of the 12 strokes, 
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Fig. 1. Homologous vein patch 14 years after implantation. Inner surface of vein is covered by 
endothelial cells (arrows; CD-31, immunostain; original magnification, 400x). 
Fig. 2. Homologous vein patch 15 years after implantation. Endothelium (E), discrete intima 
(I), media (M), and adventitia (A). (Hematoxylin and eosin stain; original magnification, 100x.) 
two were minor with minimal residual deficit and no 
functional impairment. The remaining 10 strokes 
were major. 
Three patients (0.3%) had TIAs ipsilateral to the 
endarterectomized arteryin the postoperative p riod. 
All three patients underwent computed tomographic 
scans, the results of which were negative. 
Cervical hematomas developed after surgery in 27 
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Table II. Univariate association between perioperative ariables and in-hospital 
death/neurologic morbidity 
Variable No. of patients In-house death (%) In-house CVA and TIA (%) 
Total 1006 8 (0.8%) 15 
Age _>62 yr 760 8 (1%)* 7 
Age <62 yr 246 0 (0%) 8 
Male 610 4 (0.7%) 5 
Female 396 4 (1%) 10 
Hypertension--yes 472 4 (0.9%) 7 
no 534 4 (0.7%) 8 
Diabetes--yes 122 2 (1.6%) 3 
no 884 6 (0.7%) 12 
Smoking--yes 568 4 (0.7%) 7 
no 438 4 (0.91%) 8 
Coronary artery disease--yes 362 3 (0.8%) 0 
no 644 5 (0.8%) 15 
History of CVA--yes 135 1 (0.7%) 5 
no 871 7 (0.8%) 10 
History of TIA--yes 452 4 (0.88%) 12 
no 554 4 (0.7%) 3 
Asymptomafic--yes 335 5 (1.2%) 2 
no 671 3 (0.4%) 13 
Nonhemispheric--yes 84 1 (0.75%) 2 
no 922 7 (0.8%) 13 
Redo endarterectomy--yes 33 0 (0%) 0 
no 973 8 (0.8%) 15 
Previous endarterectomy--yes 231 1 (0.4%) 2 
no 775 7 (0.9%) 13 
Combined operation--yes 107 3 (2.9%)* 2 
no 899 5 (0.6%) 13 
Contralateral stenosis _>75%--yes 115 0 (0%) 2 
no 891 8 (0.9%) 13 
Contralateral occlusion--yes 75 0 (0%) 0 
no 931 8 (0.86%) 15 
EEG§ monitor--yes 357 3 (0.85%) 2 
no 649 5 (0.7%) 13 
EEG§ change--yes 43 1 (2.3%) 1 
no 963 7 (0.7%) 14 
Carotid clamp time 
<20 rain 110 2 (1.82%) 3 
21 to 25 rain 318 3 (0.94%) 7 
>25 rain 578 3 (0.52%) 5 
Shunt--yes 53 1 (2%) 2 
no 953 7 (0.7%) 13 
Postoperative CVA--yes 12 2 (16.7%)* 
no 994 6 
Postoperative ipsilateral CVA--yes 10 2 (20%)* 
no 997 6 (0.6%) 
Postoperative Mill--yes 5 1 (20%)* 1 
no 1001 7 (0.7%) 14 
Postoperative r nal failure--yes 2 1 (50%)* 0 
no 1004 7 (0.7%) 15 
(1.5%) 
(0.9%) 
(3.25%) 
(0.8%) 
(2.53%) 
(1.5%) 
(1.5%) 
(2.5%) 
(1.36%) 
(1.2%) 
(1.83%) 
(0%) 
(2.33%) 
(3.7%)t 
(1.15%) 
(2.6%)* 
(0.54%) 
(0.6%)~ 
(1.94%) 
(1.5%) 
(1.41%) 
(0%) 
(1.54%) 
(0.9%) 
(1.68%) 
(1.9%) 
(1.45%) 
(1.7%) 
(1.46% 
(0%) 
(1.61% 
(0.56% 
(2%)* 
(2.33%) 
(1.43%) 
(2.73%) 
(2.2%) 
(0.87%) 
(4.1%) 
(1.36%) 
(20%)* 
(1.4%) 
(0%) 
(1.49%) 
*p < 0.05. 
]~p < 0.01. 
:~0.06 > p > 0.05. 
§EEG, Electroencephalogram; HMI, myocardial infarction. 
o f  the 1006 carotid endarterectomies (2.7%). Two 
patients (0.2%) required semielective vacuation o f  
the hematomas.  One pat ient who required emer- 
gency explorat ion o f  the neck had a suture-l ine 
disruption; the vein patch, however, was intact. 
Mi ld cranial nerve dysfunction was reported in 42 
cases (4.2%) after surgery. Only two patients (0.2%) 
had severe injury to the twelfth nerve with permanent  
postoperative disability. 
The univariate association between significant 
variables and perioperative mortal i ty and neurologic 
morbid i ty  rates is shown in Table I I .  On  multivariate 
analysis the factors independent ly  associated with 
early neurologic morbid i ty  were cross-clamp time 
(p < 0.05) and intraoperative electroencephalogram 
moni tor ing (p < 0.05). In patients with contralateral 
occlusion, history o f  previous CVA was also signifi- 
cant (p < 0.05). For  the group o f  individuals clas- 
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Fig. 3. Kaplan-Meier analysis hows overall survival in 482 carotid endarterectomy patients 
with homologous vein patch angioplasty. Rate of freedom from mortality is88% + 1.8% at 5 years, 
and 76% + 3.2% at 10 years. 
sifted as symptomatic (defined as having history of 
TIA or CVA or having nonhemisphere symptoms), 
clamp time (p < 0.05) was the only predictor of 
postoperative death. No risk factors appeared to 
predict death in the asymptomatic group. Because of 
the low perioperative mortality and morbidity rates 
in this group of patients, the results from the mul- 
tivariate logistic regression model must be inter- 
preted with caution. 
Late results. Follow-up data was obtained for 482 
patients (56%). The follow-up time ranged from i to 
132 months (mean, 61' months). The overall mortal- 
ity rate was 13% (63 patients). Of those deaths, two 
(0.4%) were attributed to CVAs ipsilateral to previous 
carotid endarterectomy. Twenty-five patients (40%) 
died of complications from coronary artery disease, 
six (9.6%) of cancer, four (6.3%) of renal causes, and 
three (5.0%) from pulmonary causes. Twenty-two 
patients (38.7%) died from a cause other than those 
listed above. 
During the follow-up period, neurologic ompli- 
cations developed in20 patients (4.1%). CVAs involv- 
ing the hemisphere ipsilateral to the carotid endar- 
terectomy were found in seven patients (1.5%), and 
contralateral strokes were found in another 12 pa- 
tients (2.5%). Recurrent TIAs in the territory of the 
endarterectomized carotid artery developed in one 
patient (0.2%). 
The univariate analysis between significant vari- 
ables and late mortality/neurologic morbidity rates 
is shown in Table III. Significant independent factors 
that predicted late death on the multivariate model 
included a history of diabetes (p < 0.01) and pre- 
vious carotid endarterectomy (p < 0.01). As deter- 
mined by Kaplan-Meier analysis, the 5-year overall 
survival probability was 88% + 1.8%; the 10-year sur- 
vival probability was 76% + 3.2% (Fig. 3). History of 
previous CVA (p < 0.05) appeared to predict late 
neurologic omplications (CVA or TIA in the late 
follow-up) as well as late ipsilateral neurologic om- 
plications (CVA or TIA in the territory of the en- 
darterectomized carotid artery). The rate of freedom 
from late neurologic morbidity was 97% _+ 0.8% at 5 
years and 92% + 2.2% at 10 years. The rate of free- 
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Table III. Univariate association between variables and late mortality, overall ate neurologic 
morbidity and ipsilateral neurologic morbidity (482 patients) 
Late ipsilateral 
Late death Late CVA and TIA CVA and TIA 
Variable No. of patients (%) (%) (%) 
Total 482  63 (13%) 20 (4.1%) 8 (1.7%) 
Age >62 355 52 (14.7%) 15 (4.2%) 6 (1.7%) 
Age <62 127 11 (8.7%) 5 (3.9%) 2 (1.6%) 
Sex 
Male 175 19 (11%) 7 (4%) 3 (1.7%) 
Female 307 44 (14.3%) 13 (4.2%) 5 (1.6%) 
Hypertension--yes 247 32 (13%) 10 (4%) 3 (1.2%) 
no 235 31 (13.2%) 10 (4.3%) 5 (2.1%) 
Diabetes--yes 62 16 (26%)* 3 (4.8%) 0 (0%) 
no 420 47 (11%) 17 (4%) 8 (1.9%) 
Smoking--yes 272 45 (16.5%) 11 (4%) 6 (2.2%) 
no 210 18 (8.6%) 9 (4.3%) 2 (0.95%) 
Coronary arterydisease--yes 170 25 (15%) 3 (1.8%) 0 (0%) 
no 312 38 (12.1%) 17 (5.4%) 8 (2.6%) 
History ofCVA--yes 57 8 (14%) 5 (8.8%) 1 (1.8%) 
no 425 55 (13%) 15 (3.5%) 7 (1.6%) 
History ofTIA--yes 203 25 (12.3%) 9 (4.4%) 4 (2%) 
no 279 38 (13.6%) 11 (3.9%) 4 (1.4%) 
Asymptomatic--yes 167 20 (12%) 2 (1.2%)* 1 (0.6%) 
no 315 43 (13.6%) 18 (5.7%) 7 (2.2%) 
Nonhemisphetic--yes 55 10 (18%) 4 (7.2%) 2 (3.6%) 
no 427 53 (12.4%) 16 (3.7%) 6 (1.4%) 
Redo endarterectomy--yes 19 4 (21%)t 0 (0%) 0 (0%) 
no 463 59 (12.7%) 20 (4.3%) 8 (1.7%) 
Previous endarterectomy--yes 126 26 (21%)~ 3 (2.4%) 2 (1.6%) 
no 356 37 (10.4%) 17 (4.8%) 6 (1.7%) 
Combined operation--yes 47 4 (8.5%) 0 (0%)* 0 (0%) 
no 435 59 (13.6%) 20 (4.6%) 8 (1.8%) 
Preoperative contralateral stenosis 
_>75%--yes 78 10 (12.6%) 2 (2.5%) 2 (2.5%) 
no 404 53 (13.1%) 18 (4.4%) 6 (1.5%) 
Preoperative contralateral 31 4 (12.9%) 0 (0%) 0 (0%) 
occlusion--yes 
no 451 59 (13%) 20 (4.4%) 8 (1.8%) 
Postoperative r nal failure--yes 1 0 (0%) 0 (0%) 0 (0%) 
no 481 63 (13%) 20 (4.2%) 8 (1.7%) 
Postoperative CVA and TIA--yes 7 1 (14.2%) 1 (14.2%)* 1 (14.2%)* 
no 475 62 (13%) 19 (4%) 7 (1.5%) 
Late CVA--yes 19 2 (10.5%) - -  - -  
no 463 61 (13.2%) - -  - -  
Late ipsilateral CVA--yes 7 0 (0%) - -  - -  
no 475 63 (13.3%) - -  - -  
*p < 0.05. 
tP < 0.01. 
~tp < 0.005. 
dom from late ipsilateral neurologic morbidity was 
98% + 0.7% at 5 years and 96% + 1.4% at 10 years 
(Fig. 4). 
Recurrent stenosis. The overall incidence of 
recurrent stenosis (a reduction in diameter >20%) in 
the 220 arteries studied by duplex was 11% (24. 
arteries), yet only five of these patients (2%) were 
symptomatic. Recurrent severe stenosis (a reduction 
in diameter >75%) was documented in five of the 220 
arteries (2%) studied by duplex; another four arteries 
(2%) were found to be totally occluded. Moderate 
stenosis (a reduction in diameter of 50% to 74%) was 
found in five arteries (2%), and mild stenosis (a 
reduction in diameter of 20% to 49%) was identified 
in another nine arteries (4%). 
The tmivariate association between significant 
variables and late recurrent stenosis i  shown in Table 
IV. According to the multivariate model, the predic- 
tors ofrestenosis (_>20% diameter reduction) included 
age less than 62 years (p < 0.05 ), preoperative history 
ofTIA (p < 0.05 ), and preoperative history of carotid 
endarterectomy (p< 0.01). According to Kaplan- 
Meier analysis, the rate of freedom from late signifi- 
cant restenosis (>50% diameter reduction) was 
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Fig. 4. Kaplan-Meier analysis hows rate of freedom from late neurologic morbidity in 482 
carotid endarterectomy patients with homologous vein patch angioplasty. Rate of freedom from 
overall neurologic morbidity was 97% -+ 0.8% at 5 years, and 92% _+ 2.2% at 10 years. Rate of 
freedom from ipsilateral neurologic morbidity was 98% + 0.7% at 5 years and 96% -+ 1.4% at 10 
years. 
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Fig. 5. Kaplan-Meier analysis hows rate of freedom from overall restenosis (>20% diameter 
reduction) and significant restenosis (>50% diameter eduction) in 220 cases of carotid 
endarterectomy with homologous vein patch angioplasty. Rate of freedom from significant 
restenosis was 94% + 1.8% at 5 years and 91% + 2.4% at 10 years. Freedom from overall restenosis 
was 91% + 2.2% at 5 years and 84% + 3.3% at 10 years. 
94% +- 1.8% at 5 years and 91% + 2.4% at 10 years. The 
rate o f  f reedom from overall restenosis (_>20% diam- 
eter reduct ion) was 91%_+2.2% at 5 years and 
84% + 3.3% at 10 years (Fig. 5). 
DISCUSSION 
The beneficial effects of  patch angioplasty on the 
reconstruct ion of  the carotid bifurcation after endar- 
terectomy have been demonstrated by several au- 
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Table IV. Univariate association between variables and late recurrent stenosis in 220 arteries tudied 
with duplex scan 
Recurrent stenosis .>50% Recurrent stenosis >_20% 
Variable No. of patients No. % No. % 
Total 220 14 6.36% 24 10.9% 
Age >62 139 7 5% 9 6.6% 
Age <62 81 7 8.6%* 15 17.8%{ 
Male 139 9 6.5% 17 12.2% 
Female 81 5 6.2% 7 8.6% 
Smoking--yes 208 14 6.7% 22 10.6% 
no 12 0 0.00% 2 16.7% 
Hypertension--yes 113 6 5.3% 14 12.4% 
no 107 8 7.5% 10 9.4% 
Diabetes--yes 33 2 6% 4 12.1% 
no 187 12 6.4% 20 10.7% 
History of  CVA--yes 28 3 10.7% 4 14.3 % * 
no 192 11 5.7% 20 10.4% 
History of  TIA--yes 99 6 6% 11 i i .  i % 
no 121 8 6.6% 13 10.7% 
Asymptomatic--yes 68 2 2.9% 5 7.4% 
no 152 12 7.9% 19 I2.5% 
Nonhemispheric--yes 36 3 8.3% 5 I3.9% 
no 184 11 6% 19 10.3% 
Redo endarterectomy--yes 6 2 33%* 2 33.3% 
no 214 12 5.6% 22 10.3% 
Previous endarterectomy--yes 58 6 10.3% 8 13.8% 
no 162 8 4.9% 16 9.9% 
Preoperative ipsilateral stenosis 
50% to 74% 78 2 2.6% 6 7.7% 
_>75% 142 12 8.5%* 18 12.7%* 
Contralateral stenosis _>75%--yes 35 1 2.9% 6 10.5% 
no 185 I3 7% 18 11.04% 
Contralateral occlusion--yes 14 1 7.1% 3 21.4% 
no 206 13 6.3% 21 10.2% 
*p < 0.05. tP < 0.01. 
thors. Traditionally, autologous saphenous vein has 
been used as a patch with excellent short-term and 
long-term results. 68,n,~3 Cervical veins and synthetic 
patches s,9'ls have also been used with very good 
results, but they have not achieved widespread accep- 
tance. 
Many surgeons at our institution have long been 
interested inthe use of homologous vein as a patch in 
various vascular econstructive procedures, particu- 
larly after carotid endarterectomy. The main source of 
homologous vein has been the excess vein harvested 
during coronary artery bypass operations. Initially, 
refrigeration alone was used to preserve veins, but the 
growing need to preserve the veins for long periods of 
time brought about a protocol for cryopreservation n 
collaboration with the transfusion service. Currently 
all veins are cryopreserved. 
Several experimental studies (with both animal 
and human veins) have demonstrated that minimal 
morphologic changes occur in cryopreserved veins or 
in veins refrigerated for short periods of t ime.  16-19 
Endothelial cells, basement membrane integrity, and 
vein wall collagen are all well preserved. In addition, 
both types of stored veins, in particular the cryopre- 
served ve ins ,  2°-22 retain most of their cellular and 
tissue functions on implantation. We believe, how- 
ever, that cryopreservation ffers several advantages 
over refrigeration: a more controlled method of 
preservation, a longer storage time, and possibly a 
better quality of vein at the time of implantation. 
It has been postulated that the presence of intact 
endothelium in vein patches at the time of implanta- 
tion may decrease the thrombogenicity of the endar- 
terectomizcd artery and consequently reduce the 
incidence ofmicrocmbolic strokes and carotid throm- 
bosis in the early postoperative p riod. 6Conversely, 
endothelial cells have been shown to be strongly 
immunogenic, 23 24 expressing major histocompat- 
ibility complex (MHC) class I, MHC class II, vas- 
cular endothelial cell, and non-MHC antigens. 25
Experimental studies in canine models have shown 
that the endothelium is rejected within 7 to I0 days 
after the transplantation f homologous vein. 26 Re- 
endothelialization, however, does tal~e place over a 
period of 6 months and ultimately results in a mor- 
phologically intact and functional endothelium. Mi- 
gration of endothelial cells from the adjacent artery 
is probably the greatest contributor to the reendo- 
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thelialization process. The histologic analysis of sev- 
ern vein patches harvested uring repeat operations 
during the study period demonstrated the presence 
of a discrete thin layer of endothelium and no evi- 
dence of inflammatory eaction in the wall of the vein 
(Figs. 1 and 2). These histologic haracteristics dem- 
onstrate that despite an initial rejection process the 
veins are eventually well incorporated into the re- 
cipient tissues. Given that an initial rejection of the 
transplanted vein patch is inevitable, for the past 5 
years we have routinely matched the ABO blood type 
of donor and recipient. 
Patch rupture in the early postoperative p riod is 
a potentially disastrous complication after saphenous 
vein patch angioplasty, and has already been docu- 
mented in several large series. 27,28 Several factors have 
been implicated in the development ofthis complica- 
tion, including the location and size of the harvested 
veins, the sex of the patients, and the size of the patch. 
In this series all veins were taken from the thigh and 
were considered for use if their internal diameter was 
at least 3 mm on distention. Small (<3 mm), thin- 
walled veins were discarded. Very large patches were 
trimmed appropriately tomaintain the original diam- 
eter of the bifurcation. By strictly adhering to the 
above criteria, we had a 0% incidence of patch rupture 
during the study period. The method of vein preser- 
vation and the ABO compatibility between the donor 
and the recipient are two additional factors that may 
potentially influence the propensity of a homologous 
patch to rupture. Although the mechanical properties 
of either the refrigerated or cryopreserved veins at 
specific rupture pressures have not yet been estab- 
lished by in vitro experiments, the results of this study 
indicated that the homologous vein, if properly pre- 
served, maintains its biomechanical characteristics on
implantation. The effect of the rejection process on 
the mechanical properties of the homologous vein has 
not been established in the literature. Because the 
primary target of the rejection reaction is the endo- 
thelium, it can be postulated that ABO compatibility 
may affect the thrombogenicity of the vein patch 
rather than its mechanical properties. 
Late follow-up data from 480 patients (5 6%) were 
available for analysis. The rate of freedom from late 
ipsilateral neurologic morbidity was found to be 
92% _+ 0.7% at 5 years and 96% + 1.4% at 10 years. 
These results do not differ significantly from the 
results of large series with different types of clo- 
sure. 5'6'9'11 We recognize, however, that the number 
of patients in the follow-up was smaller than in 
previous tudies, and as a consequence these results 
should be interpreted with caution. Nonetheless, 
evidence shows that the homologous vein patch is a 
durable patch and compares favorably with other 
patches that are used in the same location. 
Aneurysmal dilatation of the patch constitutes a 
potential problem when saphenous vein or vein from 
another location is used. 29 The thickness of the vein 
wall and the size of the patch may predispose the 
reconstructed area to late aneurysmal formation. 
Application of a patch that is too wide results in 
exaggerated distention of the vessel and promotes 
aneurysmal formation. In follow-up ultrasonography 
of 220 vessels, we did not find any incidence of 
aneurysmal dilatation of the patch. Although the 
number of vessels studied was relatively small, the 
follow-up duplex time was long enough to allow a 
meaningful evaluation of the above results. A vein 
patch of good quality, applied so that it does not 
increase significantly the size of the bifurcation, may 
significantly aid in preventing this complication. 
The incidence of late stenosis (>_20% diameter 
reduction) and occlusion in the group of 220 arteries 
studied by duplex scan was 11% (n = 24). Hemo- 
dynamically significant stenosis (---50% diameter e- 
duction) was present in 14 cases (6%). These long- 
term results compare favorably with the results from 
other large series that used various types of patch 
closure. ~,6,8,9 Several factors related to the use of 
homologous vein may influence the rate of late 
restcnosis, namely the method of preservation and, 
more importantly, the rejection reaction that follows 
its implantation. Recognizing the potential effect of 
rejection in the long-term patency of the patch 
angioplasty, we have adopted routine ABO matching 
between the donor and recipient since 1989. The 
effect of either technique of vein preservation (re- 
frigeration vs cryopreservation) on the rate of re- 
current stenosis is difficult to assess from this ret- 
rospective study. Both techniques preserve the mor- 
phologic characteristics and endothelial functions of 
the vein, although cryopreservation allows a longer 
storage time. For that reason, cryopreservation was 
used in the majority of cases during the last 7 years 
of the study. 
The cost of processing and preserving homolo- 
gous vein is rather low. In our institution the total cost 
is approximately $150. In addition, the facilities 
required are available in most hospital blood banks. 
Consequently, the use of homologous vein for recon- 
struction of the bifurcation i  carotid endarterectomy 
offers the advantage of an "off-the-shelf" biologic 
patch at a relative low cost and avoids the need for 
harvesting vein, with its attendant problems. 
Our early neurologic mortality and morbidity 
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rates do not  differ from those obtained by centers o f  
excellence that use rout ine patching o f  the bifurcation 
after carotid endarterectomy. 6,7,n In addit ion, the 
incidences o f  late ipsilateral neurologic morbid i ty  and 
recurrent stenosis compare favorably with those from 
other large series that have more complete fol low-up 
data. A l though the long-term behavior o f  the ho- 
mologous vein requires further evaluation, we be- 
lieve that the excellent perioperative r sults obtained 
in this study, along with the current long-term results, 
make the homologous  vein an acceptable patch for 
reconstruct ion o f  the bifurcation after carotid endar- 
terectomy. 
We thank Jerry Eastman and Zhi-Dong Jiang for 
preparing this manuscript. 
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